Search results
Results from the WOW.Com Content Network
Nodular sclerosis is a type of Hodgkin lymphoma, a cancer of the lymphatic system. Learn about the condition’s symptoms, causes and treatment options. We're available 24/7.
NSHL occurs most commonly between the ages of 15 and 35 and affects equal numbers of males and females. Treatment most often includes chemotherapy with or without radiation, and monoclonal antibody therapy or a stem cell transplant may be needed in the advanced stages or with a recurrence.
Treatment for many patients is chemotherapy (usually 2 to 4 cycles of the ABVD regimen), followed by radiation to the initial site of the disease (involved site radiation therapy, or ISRT). Another option is chemotherapy alone (usually for 3 to 6 cycles) in selected patients.
Hodgkin lymphoma treatment depends on the type (classical or nodular lymphocyte predominant) and includes chemotherapy and/or radiation therapy. Get detailed information about the prognosis and treatment of newly diagnosed and recurrent Hodgkin lymphoma in this expert-reviewed summary.
Treatment may involve chemotherapy with or without radiation or, in advanced cases, a stem cell transplant. NSHL is a subtype of classical HL. It is the most common type of HL in...
Hodgkin lymphoma treatment depends on the type (classical or nodular lymphocyte predominant) and includes chemotherapy and/or radiation therapy. Get comprehensive information on newly diagnosed and recurrent Hodgkin lymphoma treatment in this summary for clinicians.
There are four classic Hodgkin lymphoma subtypes: Nodular sclerosing Hodgkin lymphoma: This is the most common classic Hodgkin lymphoma subtype. It often affects young adults, especially women and people designated female at birth (DFAB).
Individualized treatment may be necessary for older patients and those with concomitant disease. Consistent with NCCN philosophy, participation in clinical trials is always encouraged. This portion of the guidelines discusses recommendations for the workup, diagnosis, and management of CHL.
Approximately three-quarters of patients with Hodgkin’s lymphoma in advanced stages (stages III and IV) can be cured with chemotherapy. The chemotherapy scheme most widely used is the combination of doxorubicin, bleomicin, vinblastin, and dacarbazine (ABVD).
For Hodgkin lymphoma, radiation can be aimed at affected lymph nodes and the nearby areas where the disease might spread. It's usually used with chemotherapy. Radiation therapy may be the only treatment needed for early-stage nodular lymphocyte-predominant Hodgkin lymphoma.